Evidence map›Paper›PMID 27505674›Full record

ArticleCancer cell2016

RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.

Flavia Pichiorri, Sung-Suk Suh, Alberto Rocci, Luciana De Luca, Cristian Taccioli, Ramasamy Santhanam, Wenchao Zhou, Don M Benson, Craig Hofmainster, Hansjuerg Alder and 9 more

RetractedAbstract readPublished ErratumRetracted Publication
PubMed Publisher
In one paragraph

Article in Cancer cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. miRNA-based biomarkers, therapies, and resistance in Cancer.International journal of biological sciences · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Flavia Pichiorri
Sung-Suk Suh
Alberto Rocci
Luciana De Luca
Cristian Taccioli
Ramasamy Santhanam
Wenchao Zhou
Don M Benson
Craig Hofmainster
Hansjuerg Alder
Michela Garofalo
Gianpiero Di Leva
Stefano Volinia
Huey-Jen Lin
Danilo Perrotti
Michael Kuehl
Rami I Aqeilan
Antonio Palumbo
Carlo M Croce

Funding

Role of microRNAs in the regulation of CML stem cell survival and self renewalR01CA163800 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI PERROTTI, DANILO · 2012 to 2017
$1.6M
Validation of microRNAs as therapeutic targets in hematological malignanciesR01CA135332 · NCI · OHIO STATE UNIVERSITY · PI MARCUCCI, GUIDO, MUTHUSAMY, NATARAJAN · 2011 to 2015
$1.6M
Cancer Research UK 20465NCI NIH HHS R01 CA135332NCI NIH HHS R01 CA163800
6 · The paper itself

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the editors. This correction has been retracted because the article that it relates to has now been retracted at the request of the editors.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.